Quick context
GHK-Cu
研究涉及皮肤基质、胶原信号及创伤模型；美容领域讨论不代表获批医疗效果。
No generally accepted approved dose exists. Online amounts vary by material, purity, route and source and prove neither safety nor efficacy.
Back to all 64 profiles
Community/research information only未获 FDA/EMA 批准
Community protocol · GHK-Cu
GHK-Cu: community information and evidence, clearly separated.
A complete substance profile covering documented community themes, scientific context and explicit safety boundaries. Missing or non-standardised data are not replaced with estimates.
Also known as: Copper peptide · Copper tripeptide-1 · GHK Copper
Sources checked: 27 August 2026
重要安全与责任声明
本页记录并评估网络社区信息，不构成医疗或治疗建议、个体咨询，也不是使用邀请。
No medical, therapeutic or individual recommendation. Information is provided without warranty and used at your own risk. No liability for calculation errors, use, contamination, interactions or consequences.
Amounts, timing and cycles
Community/research information only
No generally accepted approved dose exists. Online amounts vary by material, purity, route and source and prove neither safety nor efficacy.
Amount status
Different amounts circulate online; no regulator-confirmed safe or effective dose exists.
Profile evidence level: preclinical.
Timing
Community claims about time of day, fasting windows or training intervals are not validated clinical standards.
No individual recommendation.
Cycle/duration
Cycles and breaks are community constructs and do not prevent adverse effects or unknown long-term consequences.
No individual recommendation.
External community reference available
The external page is used only to document community claims. Advertising and affiliate material were excluded; its content is neither approval nor proof of quality.
Open community source复配与 U-100 换算
No generic calculator
Reconstitution is not generally applicable to this substance or product class. Form, concentration and handling must come from the exact authentic product and its official labelling.
Reconstitution is not generally applicable to this substance or product class. Form, concentration and handling must come from the exact authentic product and its official labelling.
Mechanism and research questions
Naturally occurring copper-binding tripeptide
GHK-Cu is classified as “Naturally occurring copper-binding tripeptide”. 研究涉及皮肤基质、胶原信号及创伤模型；美容领域讨论不代表获批医疗效果。 This describes the investigated pathway but does not validate a community use, amount, route or combination.
铜结合三肽
这项研究考察一种短肽如何结合铜离子,并可能支持皮肤组织中的细胞信号传导,类似于运输重要微量元素的容器。在皮肤模型中测量胶原蛋白标志物和细胞活性。
皮肤基质信号传导
这项研究考察信号如何影响赋予皮肤紧致和弹性的胶原蛋白及其他结构蛋白,类似于研究建筑物表面之下的支架结构。研究人员通常在实验室皮肤模型中测量胶原蛋白生成和皮肤结构。
细胞迁移肽
这项研究考察某肽如何影响细胞向损伤部位的迁移,类似于工人们赶往施工现场。在实验室模型中测量细胞迁移的速度和程度。
What communities discuss
These themes describe discussion and vendor claims. They do not prove benefit, safety, product identity or suitable use.
皮肤和头发轶事
用户交流使用美容宣传的肽产品后关于皮肤外观、皱纹深度或头发生长的个人印象,通常基于自己的照片而非测量设备。这类主观印象和营销宣传并不能证明确切的效果。
来源与纯度讨论
人们讨论哪些商家被认为更值得信赖,以及不同批次之间纯度检测结果的差异。这类社区评估基于有限的样本,无法替代对每一批次进行的独立实验室检测。
伤口愈合轶事
人们报告在使用某些肽后感觉伤口或肌腱问题愈合更快,通常没有对照组或客观测量。这类个人经历并不能证明实际的疗效或安全性。
Adverse effects and risk boundaries
- 外用物质可引起刺激、致敏或接触性过敏；注射或剂型不明会显著增加全身性、无菌及污染风险。
- Local reaction, infection, abscess and contamination are possible with any injection that is not professionally manufactured and administered.
- A label or clear appearance does not exclude unknown purity, wrong identity, endotoxins or concentration errors.
Exclusion groups and professional assessment
- 开放或感染皮肤、已知过敏、妊娠及原因不明的皮肤变化，在美容或医疗使用前应接受专业评估。
- Acute symptoms, allergic reaction, breathing difficulty, chest pain, neurological deficits or severe abdominal pain require immediate medical care.
- Children and adolescents, pregnancy/breastfeeding, and people with relevant disease should not be part of unsupervised experiments.
Monitoring and laboratory markers
- 皮肤反应、记录使用面积/浓度及出现刺激时停用，比血液检查更相关；全身使用需另行医学评估。
- Baseline, objective, measurement timing and stop criteria must be defined professionally in advance. Individual laboratory values cannot compensate for unknown product quality.
Evidence boundary
临床前
化妆品相关讨论并不能证明其具有经批准的医学效果。
Published evidence
现有数据主要来自动物或细胞模型;缺乏可靠的人体有效性和安全性数据。
GHK-Cu是一种天然存在的铜三肽,不同于经过合成修饰的AHK-Cu。
Storage and stability
- The manufacturer label and prescribing information take priority. Storage instructions from a different product do not transfer.
- Unapproved vials often lack dependable stability data before and after mixing; ‘2–8 °C’ or ‘28 days’ is not a universal standard.
- Do not use after seal damage, particles, cloudiness, discoloration, unknown date or interrupted cold chain. Visual inspection does not prove sterility.
Troubleshooting and error sources
- U-100 units measure volume, not drug amount: 100 U equals 1 mL. A wrong concentration makes every unit figure wrong.
- Do not shake or dilute further to ‘fix’ cloudiness, particles or uncertain solubility; discard and obtain professional clarification.
- Do not calculate a double or extra amount to compensate for missed use or an uncertain injection.
- Without a COA, clear supplier, correct label and consistent vial information, identity is not confirmed.
Regulatory status and WADA
未获 FDA/EMA 批准
没有 FDA 或 EMA 批准的药品；有效性与安全性尚未确立。
WADA 2026
The atlas has no explicit WADA flag for this profile. That does not automatically mean every form, route or related class is permitted in sport.
WADA — 2026 Prohibited ListComparisons and related profiles
Combinations / stacks
- Combinations change effects, adverse effects and laboratory values; evidence for one substance does not establish the safety of a stack.
- Overlapping pathways may add up. Hormonal, glucose, blood-pressure, coagulation, immune and sedating effects are important potential interactions.
- Non-standardised blends prevent separate dosing, cause attribution and dependable reconstitution.
Frequently asked questions
Is an amount shown here a recommendation?
No. This page separates approved product information, study protocols and community information. No number or calculator is an individual dosing recommendation.
Does the U-100 calculator prove correct use?
No. It only converts mass, volume and syringe scale. It cannot check identity, purity, sterility, stability, solvent or medical suitability.
Can this profile be combined with other substances?
Safety of a combination cannot be inferred from a single-substance profile. Overlapping pathways, medicines and undefined blends can increase risk.
Which source controls when information conflicts?
For approved medicines, the current prescribing information and treating professional control. For research substances, conflict shows that no dependable self-use standard exists.
Are community claims clinical evidence?
No. Anecdotes can generate questions but do not replace controlled studies, regulatory review, or identity and quality testing.
Sources and evidence layers
Primary sources and official registries take priority. The community reference is labelled separately.
- Primary/technical sourcePubMed: GHK-Cu fibroblast research
- Primary/technical sourceFDA: 2026 peptide advisory review
- Community referenceGHK-Cu — Peptide Dosing Protocols